Low-Fat, High Fruit and Vegetable Diets and Weight Loss Do Not Affect Biomarkers of Cellular Proliferation in Barrett Esophagus

Risk factors for esophageal adenocarcinoma include obesity, high fat intake, and low consumption of fruits and vegetables. This trial tested whether an intervention to reduce these risk factors in patients with Barrett esophagus, a preneoplastic condition for esophageal adenocarcinoma, could reduce biomarkers of cellular proliferation and, by inference, the risk of neoplastic progression. Eighty-seven men and women with Barrett esophagus were randomized to an intensive dietary intervention or control group. At baseline, 18 and 36 months after intervention, biopsies were obtained at 2-cm intervals throughout the length of the Barrett segment. Ki67/DNA content flow cytometry was used to assess (a) % Ki67-positive proliferating diploid G1 cells, (b) % total Ki67-positive proliferating cells, (c) presence of aneuploidy, and (d) presence of >6% of cells in the 4N (G2/tetraploid) fraction of the cell cycle. We also assessed re-epithelialization and length of the Barrett segment, reflux symptoms, and medication use. The intervention effects for energy, fat, fruits and vegetables, and weight were, respectively, −314 kcal, −12.2% energy, 1.8 servings/d, and −4.0 kg at 18 months (all P < 0.005) and were smaller but remained significant at 36 months. There were no significant effects of the intervention on any biomarker of cellular proliferation. The intervention effects ± SE for mean %G1 Ki67+ cells were 0.98 ± 1.58 at 18 months and 1.79 ± 1.31 at 36 months; the relative risks (95% confidence interval) for developing >6% of cells in 4N were 0.5 (0.1-2.6) at 18 months and 0.75 (0.2-3.1) at 36 months. A single control participant developed aneuploidy. There were no significant effects on re-epithelialization, segment length, or reflux medication use. We conclude that substantial dietary change has no short-term effects on biomarkers of cellular proliferation in Barrett esophagus or on clinical observations of the Barrrett segment.

[1]  M. Blaser,et al.  Population attributable risks of esophageal and gastric cancers. , 2003, Journal of the National Cancer Institute.

[2]  Jenny Donovan,et al.  Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. , 2003, International journal of epidemiology.

[3]  K. Hveem,et al.  Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. , 2003, JAMA.

[4]  S. Mayne,et al.  Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. , 2002, The Journal of nutrition.

[5]  Carissa A. Sanchez,et al.  Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  P. I. Reed,et al.  Lifestyle factors and Barrett's esophagus , 2002, American Journal of Gastroenterology.

[7]  L. Brown,et al.  Epidemiologic trends in esophageal and gastric cancer in the United States. , 2002, Surgical oncology clinics of North America.

[8]  P. Moayyedi,et al.  Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. , 2002, Gastroenterology.

[9]  C. Ciacci,et al.  The use of serum tTG-ab assay in patients on gluten-free diet as a measure of dietetic compliance. , 2002, Gastroenterology.

[10]  C. Miller,et al.  Incidence and Survival Trends of Esophageal Carcinoma in the United States: Racial and Gender Differences by Histological Type , 2002, Scandinavian journal of gastroenterology.

[11]  R. Penagini,et al.  Effect of Calories and Fat on Postprandial Gastro-oesophageal Reflux , 2002, Scandinavian journal of gastroenterology.

[12]  D. Weisenburger,et al.  Nutrient Intakes and Adenocarcinoma of the Esophagus and Distal Stomach , 2002, Nutrition and cancer.

[13]  Patricia L. Blount,et al.  p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. , 2001, Cancer research.

[14]  M. Gammon,et al.  Nutrient intake and risk of subtypes of esophageal and gastric cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  P. Blount,et al.  Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. , 2001 .

[16]  Carissa A. Sanchez,et al.  Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression , 2001, American Journal of Gastroenterology.

[17]  A. Wolk,et al.  Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[18]  陈贻胜,et al.  Barrett's食管 , 2001 .

[19]  A. Meining,et al.  The role of diet and lifestyle measures in the pathogenesis and treatment of gastroesophageal reflux disease , 2000, American Journal of Gastroenterology.

[20]  R. Sandler,et al.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus? , 2000, Gastroenterology.

[21]  Patricia L. Blount,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .

[22]  Gary Longton,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.

[23]  S. Mobarhan,et al.  Association between body mass index and adenocarcinoma of the esophagus and gastric cardia. , 2000, Nutrition reviews.

[24]  A. Kristal,et al.  Waist-to-Hip Ratio, Weight Gain, and Dietary and Serum Selenium Are Associated With DNA Content Flow Cytometry in Barrett's Esophagus , 2000, Nutrition and cancer.

[25]  J. Everhart,et al.  Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey. , 1999, Annals of epidemiology.

[26]  C. Lewis,et al.  The Women's Health Trial Feasibility Study in Minority Populations: changes in dietary intakes. , 1999, American journal of epidemiology.

[27]  J. Lagergren,et al.  Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia , 1999, Annals of Internal Medicine.

[28]  A R Zinsmeister,et al.  Risk factors associated with symptoms of gastroesophageal reflux. , 1999, The American journal of medicine.

[29]  C. Pehl,et al.  Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal reflux in healthy subjects , 1999, American Journal of Gastroenterology.

[30]  A. Kristal,et al.  Measurement characteristics of the Women's Health Initiative food frequency questionnaire. , 1999, Annals of epidemiology.

[31]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[32]  R. Sampliner,et al.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.

[33]  R. Penagini,et al.  Effect of increasing the fat content but not the energy load of a meal on gastro-oesophageal reflux and lower oesophageal sphincter motor function , 1998, Gut.

[34]  M. Gammon,et al.  Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[35]  M. Gammon,et al.  Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. , 1998, Journal of the National Cancer Institute.

[36]  D. Bowen,et al.  Feasibility of using volunteer research staff to deliver and evaluate a low-fat dietary intervention: the American Cancer Society Breast Cancer Dietary Intervention Project. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  L. Signorello,et al.  Diet and risk of esophageal cancer by histologic type in a low‐risk population , 1996, International journal of cancer.

[38]  C. Lewis,et al.  The Women's Health Trial Feasibility Study in Minority Populations: design and baseline descriptions. , 1996, Annals of epidemiology.

[39]  A. Kristal,et al.  Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[40]  R. Hayes,et al.  Adenocarcinoma of the esophagus: role of obesity and diet. , 1995, Journal of the National Cancer Institute.

[41]  M. Anselmino,et al.  Effect of gastroduodenal juice and dietary fat on the development of barrett's esophagus and esophageal neoplasia: An experimental rat model , 1994, Annals of Surgical Oncology.

[42]  T. Smyrk,et al.  Metabolism of carcinogenic nitrosamines in the rat and human esophagus and induction of esophageal adenocarcinoma in rats. , 1993, Endoscopy.

[43]  Patricia L. Blount,et al.  An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. , 1993, Gastroenterology.

[44]  Carissa A. Sanchez,et al.  Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. , 1993, Gastroenterology.

[45]  E. Wynder,et al.  Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia , 1993, Cancer Causes & Control.

[46]  B. Reid,et al.  Endoscopic biopsy technique for acquiring larger mucosal samples. , 1991, Gastrointestinal endoscopy.

[47]  D. Castell,et al.  Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. , 1991, Archives of internal medicine.

[48]  D Feskanich,et al.  Computerized collection and analysis of dietary intake information. , 1989, Computer methods and programs in biomedicine.

[49]  W. Wu,et al.  A comparison of high and low fat meals on postprandial esophageal acid exposure. , 1989, The American journal of gastroenterology.

[50]  I. Beck,et al.  Lower esophageal sphincter pressure and gastroesophageal pressure gradients in excessively obese patients. , 1988, Journal of medicine.

[51]  K. Kerlikowske,et al.  Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. , 2003, Gastroenterology.

[52]  R. Sampliner,et al.  Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus , 2002, American Journal of Gastroenterology.

[53]  D. Weisenburger,et al.  Dietary patterns and adenocarcinoma of the esophagus and distal stomach. , 2002, The American journal of clinical nutrition.

[54]  P. Dítě,et al.  [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.

[55]  Zuo-Feng Zhang,et al.  Adenocarcinomas of the esophagus and gastric cardia: the role of diet. , 1997, Nutrition and cancer.

[56]  P. Blount,et al.  Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.